Flavoring Agent · CAS 13341-72-5

Mintlactone

FDA status: Approved. EU: not separately listed. No U.S. state has enacted a specific ban yet.

Low Risk
Score 4 of 5
Mintlactone: 4/5 (Low Risk)

According to the U.S. Food and Drug Administration, Mintlactone is FDA-approved, and no U.S. state has moved to restrict it independently of federal policy.

Browse all Flavoring Agent additives →

The verdict

Mintlactone is FDA-approved, and no U.S. state has moved to restrict it.

4/5
Low Risk
Approved
FDA status
-
EU status
0
state regulations

Mintlactone: the CAS-identified regulatory record

Mintlactone: no OFF product match; CAS 13341-72-5 is the lead registry handle on this row.

Property Value Source
CAS Number 13341-72-5 CAS Registry
FDA Status Approved FDA SAFFA
EU Status Not separately listed EC 1333/2008
E-Number - EU additive register
Category Flavoring Agent FDA functional class
Composite Safety Score 4 / 5 (Low Risk) PlainIngredients methodology
EFSA ADI Not in our EFSA data EFSA scientific opinion
U.S. State Actions 0 states State legislative records
Tracked Products Not yet tracked Open Food Facts (US)

Values reflect official agency classifications as published by the U.S. Food and Drug Administration and the European Union's regulatory framework. See our methodology for scoring details.

What is Mintlactone?

Mintlactone (CAS 13341-72-5) is an FDA-regulated food substance used as flavoring agent or adjuvant.

Common Uses

flavoring agent or adjuvant

Catalog-profile peer axes

Mintlactone among its nationwide catalog-profile peers

Product-count (0) and safety-score (4/5) peer columns, disjoint link sets.

Score 4/5 peers (≥50 OFF products)

Nearest other additives by PlainIngredients safety score (floored at ≥50 tracked products), distinct from the count row.

8 peers

Frequently Asked Questions

Is Mintlactone safe to consume?

Mintlactone scores 4/5 (Low Risk). FDA status is Approved. No OFF product match yet; the distinctive registry handle is CAS 13341-72-5, so this page leads with the chemical identity row rather than a shelf-prevalence claim.